Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

intranasal

intranasal is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 7
Pipeline programs 14
News articles 0
Drug details — intranasal
Class
—
Route
—
Patents
7
Programs
14
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

intranasal is an FDA-listed pharmaceutical active ingredient.

Key facts

INN intranasal

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 54135419SUI3003 Phase 3 · Janssen-Cilag International N.V · Major Depressive Disorder
  2. Intranasal Fentanyl Spray (INFS) Phase 3 · Takeda · Break Through Pain
  3. Intranasal challenge drug Phase 3 · Indivior Pty · Heroin Dependence
  4. 1. Intranasal oxytocin spray Phase 2 · United Therapeutics Europe · Autism Spectrum Disorder
  5. Intranasal Oxytocin Phase 2 · United Therapeutics Europe · Autism Spectrum Disorder
  6. CLI-06467AC1-02 Phase 1 · Chiesi Farmaceutici S.p.A · Neonatal Hypoxic-Ischemic Encephalopathy (HIE), Neonatal Hyp
  7. INFS (Intranasal Fentanyl Spray) Phase 1 · Takeda · Healthy Volunteers
  8. Intranasal Oxytocin (IN-OXT) Phase 1 · Tonix Pharmaceuticals Holding · Vasopressin Deficiency

Related patents

Browse patents

  1. US 11224646

    Intranasal delivery of a cyclic-di-nucleotide adjuvanted vaccine for tuberculosis

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10682310

    Therapeutic compounds and formulations for intranasal delivery

    Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10543283

    Intranasal administration of guanidinylated aminoglycosides

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9757468

    Intranasal administration of guanidinylated aminoglycosides

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9592207

    Intranasal administration of ketamine to treat depression

    Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8518390

    Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7112332

    Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides

    Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is intranasal?

intranasal is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.